| Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses O Garin, M Ferrer, À Pont, M Rué, A Kotzeva, I Wiklund, E Van Ganse, ... Quality of Life Research 18 (1), 71-85, 2009 | 282 | 2009 |
| Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997–2003 T Walley, P Folino‐Gallo, P Stephens, E Van Ganse, EuroMedStat Group British journal of clinical pharmacology 60 (5), 543-551, 2005 | 259 | 2005 |
| The PAIN study: Paracetamol, Aspirin and Ibuprofen New tolerability study: a large-scale, randomised clinical trial comparing the tolerability of aspirin, ibuprofen and … N Moore, EV Ganse, JML Parc, R Wall, H Schneid, M Farhan, F Verrière, ... Clinical drug investigation 18 (2), 89-98, 1999 | 241 | 1999 |
| Integrated care pathways for airway diseases (AIRWAYS-ICPs) J Bousquet, A Addis, I Adcock, I Agache, A Agusti, A Alonso, ... European Respiratory Journal 44 (2), 304-323, 2014 | 234 | 2014 |
| Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis–a EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement PW Hellings, WJ Fokkens, C Bachert, CA Akdis, T Bieber, I Agache, ... Allergy 72 (9), 1297-1305, 2017 | 214 | 2017 |
| Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): change management in allergic rhinitis and asthma multimorbidity using mobile technology J Bousquet, PW Hellings, I Agache, F Amat, I Annesi-Maesano, ... Journal of Allergy and Clinical Immunology 143 (3), 864-879, 2019 | 209 | 2019 |
| Persistent asthma: disease control, resource utilisation and direct costs E Van Ganse, L Laforest, G Pietri, JP Boissel, F Gormand, R Ben-Joseph, ... European Respiratory Journal 20 (2), 260-267, 2002 | 194 | 2002 |
| MASK 2017: ARIA digitally‐enabled, integrated, person‐centred care for rhinitis and asthma multimorbidity using real‐world‐evidence J Bousquet, S Arnavielhe, A Bedbrook, M Bewick, D Laune, ... Clinical and translational allergy 8 (1), 45, 2018 | 191 | 2018 |
| Is diet partly responsible for differences in COVID‐19 death rates between and within countries? J Bousquet, JM Anto, G Iaccarino, W Czarlewski, T Haahtela, A Anto, ... Clinical and translational allergy 10 (1), 16, 2020 | 185 | 2020 |
| What we mean when we talk about adherence in respiratory medicine B Vrijens, AL Dima, E Van Ganse, JFM van Boven, MN Eakin, JM Foster, ... The Journal of Allergy and Clinical Immunology: In Practice 4 (5), 802-812, 2016 | 171 | 2016 |
| Variations and increase in use of statins across Europe: data from administrative databases T Walley, P Folino-Gallo, U Schwabe, E van Ganse Bmj 328 (7436), 385-386, 2004 | 170 | 2004 |
| Effects of antihistamines in adult asthma: a meta-analysis of clinical trials E Van Ganse, L Kaufman, MP Derde, JC Yernault, L Delaunois, ... European Respiratory Journal 10 (10), 2216-2224, 1997 | 166 | 1997 |
| Cabbage and fermented vegetables: from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19 J Bousquet, JM Anto, W Czarlewski, T Haahtela, SC Fonseca, G Iaccarino, ... Allergy 76 (3), 735-750, 2021 | 162 | 2021 |
| Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study EV Ganse, L Laforest, E Alemao, G Davies, S Gutkin, D Yin Current medical research and opinion 21 (9), 1389-1399, 2005 | 160 | 2005 |
| Next‐generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases JJ Bousquet, HJ Schünemann, A Togias, M Erhola, PW Hellings, ... Clinical and translational allergy 9 (1), 44, 2019 | 158 | 2019 |
| Ongoing pharmaceutical reforms in France: implications for key stakeholder groups C Sermet, V Andrieu, B Godman, E Van Ganse, A Haycox, JP Reynier Applied health economics and health policy 8 (1), 7-24, 2010 | 151 | 2010 |
| Handling of allergen immunotherapy in the COVID‐19 pandemic: an ARIA‐EAACI statement L Klimek, M Jutel, C Akdis, J Bousquet, M Akdis, C Bachert, I Agache, ... Allergy 75 (7), 1546-1554, 2020 | 150 | 2020 |
| Guidance to 2018 good practice: ARIA digitally‐enabled, integrated, person‐centred care for rhinitis and asthma J Bousquet, A Bedbrook, W Czarlewski, GL Onorato, S Arnavielhe, ... Clinical and translational allergy 9 (1), 16, 2019 | 148 | 2019 |
| Influence of patients' characteristics and disease management on asthma control L Laforest, E Van Ganse, G Devouassoux, J Bousquet, S Chretin, ... Journal of Allergy and Clinical Immunology 117 (6), 1404-1410, 2006 | 143 | 2006 |
| Rhinitis associated with asthma is distinct from rhinitis alone: the ARIA‐MeDALL hypothesis J Bousquet, E Melén, T Haahtela, GH Koppelman, A Togias, R Valenta, ... Allergy 78 (5), 1169-1203, 2023 | 130 | 2023 |
